HC Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.28M Sell
62,620
-116
-0.2% -$5.91K 2.2% 10
2022
Q1
$3.25M Sell
62,736
-3,967
-6% -$206K 1.93% 13
2021
Q4
$3.94M Buy
66,703
+439
+0.7% +$21.8K 2.19% 10
2021
Q3
$2.85M Buy
66,264
+183
+0.3% +$8.11K 1.71% 17
2021
Q2
$2.59M Buy
66,081
+369
+0.6% +$14.3K 1.51% 22
2021
Q1
$2.38M Buy
65,712
+2,727
+4% +$96.8K 1.45% 25
2020
Q4
$2.32M Sell
62,985
-3,146
-5% -$115K 1.49% 23
2020
Q3
$2.3M Buy
66,131
+741
+1% +$26K 1.65% 19
2020
Q2
$2.03M Sell
65,390
-421
-0.6% -$14.3K 1.58% 20
2020
Q1
$2.04M Buy
65,811
+1,460
+2% +$49.7K 1.82% 17
2019
Q4
$2.39M Sell
64,351
-2,338
-4% -$83.3K 1.88% 19
2019
Q3
$2.27M Sell
66,689
-231
-0.3% -$8.4K 1.95% 18
2019
Q2
$2.75M Sell
66,920
-1,757
-3% -$69.8K 2.74% 12
2019
Q1
$2.77M Buy
+68,677
New +$2.75M 2.9% 13
2018
Q4
Sell
-78,544
Closed -$3.28M 51
2018
Q3
$3.28M Buy
78,544
+403
+0.5% +$15.5K 2.9% 7
2018
Q2
$2.69M Buy
78,141
+397
+0.5% +$13.6K 2.62% 8
2018
Q1
$2.62M Sell
77,744
-390
-0.5% -$13.4K 2.58% 7
2017
Q4
$2.69M Buy
+78,134
New +$2.66M 2.6% 8

Other funds holding PFE

HC Financial Advisors's PFE Position: Q2 2022 in Review

HC Financial Advisors reduced its Pfizer (PFE) stake by 0.18% in Q2 2022, selling an estimated $5.91K and leaving 62,620 shares worth $3.28M. The position accounts for 2.2% of the portfolio, ranked #10.

HC Financial Advisors first reported a position in PFE in Q4 2017 and has held it in 18 quarters since. The position peaked at $3.94M in Q4 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • HC Financial Advisors held 62,620 shares of Pfizer worth $3.28M as of Q2 2022.
  • HC Financial Advisors sold 116 Pfizer shares in Q2 2022, an estimated $5.91K.
  • Pfizer made up 2.2% of HC Financial Advisors's portfolio in Q2 2022, its #10 holding.
  • HC Financial Advisors first reported a position in Pfizer in Q4 2017 and has held it in 18 quarters since.
  • HC Financial Advisors's Pfizer position peaked at $3.94M in Q4 2021.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on HC Financial Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.